In support of this possibility, we have previously demonstrated that heterozygous CDK5 deficiency reverses hyperphosphorylation of tau in mature neurons in the frontal cortex of gp120 tg mice [8], and that CDK5 knock-down rescues neurogenic deficits in an animal model of AD [17]. This evidence concerns the gene MAPT and Alzheimer disease.